Cargando…

Manufacturing clinical‐grade human induced pluripotent stem cell‐derived beta cells for diabetes treatment

The unlimited proliferative capacity of human pluripotent stem cells (hPSCs) fortifies it as one of the most attractive sources for cell therapy application in diabetes. In the past two decades, vast research efforts have been invested in developing strategies to differentiate hPSCs into clinically...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Lay Shuen, Chen, Juin Ting, Lim, Lillian Yuxian, Teo, Adrian Kee Keong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357357/ https://www.ncbi.nlm.nih.gov/pubmed/35474596 http://dx.doi.org/10.1111/cpr.13232

Ejemplares similares

Protocol for the generation of pancreatic and hepatic progenitors from human pluripotent stem cells for gene regulatory assays
por: Tan, Lay Shuen, et al.
Publicado: (2021)

Knowledge Gaps in Rodent Pancreas Biology: Taking Human Pluripotent Stem Cell-Derived Pancreatic Beta Cells into Our Own Hands
por: Santosa, Munirah Mohamad, et al.
Publicado: (2016)

Dissecting diabetes/metabolic disease mechanisms using pluripotent stem cells and genome editing tools
por: Teo, Adrian Kee Keong, et al.
Publicado: (2015)

Scalable manufacturing of clinical‐grade differentiated cardiomyocytes derived from human‐induced pluripotent stem cells for regenerative therapy
por: Morita, Yuika, et al.
Publicado: (2022)

Distributed automated manufacturing of pluripotent stem cell products
por: Shariatzadeh, Maryam, et al.
Publicado: (2019)

HNF4A Haploinsufficiency in MODY1 Abrogates Liver and Pancreas Differentiation from Patient-Derived Induced Pluripotent Stem Cells
por: Ng, Natasha Hui Jin, et al.
Publicado: (2019)

End-to-End Platform for Human Pluripotent Stem Cell Manufacturing
por: Pandey, Puspa R., et al.
Publicado: (2019)

A Scalable and Efficient Bioprocess for Manufacturing Human Pluripotent Stem Cell-Derived Endothelial Cells
por: Lin, Haishuang, et al.
Publicado: (2018)

Engineered Microenvironment for Manufacturing Human Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells
por: Lin, Haishuang, et al.
Publicado: (2018)

Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies
por: Shankar, Keerthana, et al.
Publicado: (2020)

Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications
por: Baghbaderani, Behnam Ahmadian, et al.
Publicado: (2016)

Challenges and Solutions for Commercial Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products
por: Lee, Brian, et al.
Publicado: (2020)

Transgene Reactivation in Induced Pluripotent Stem Cell Derivatives and Reversion to Pluripotency of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells
por: Galat, Vasiliy, et al.
Publicado: (2016)

Development of genetic quality tests for good manufacturing practice-compliant induced pluripotent stem cells and their derivatives
por: Jo, Hye-Yeong, et al.
Publicado: (2020)

Clinical-Grade Human Pluripotent Stem Cells for Cell Therapy: Characterization Strategy
por: Rehakova, Daniela, et al.
Publicado: (2020)

Serum-Free Manufacturing of Mesenchymal Stem Cell Tissue Rings Using Human-Induced Pluripotent Stem Cells
por: Winston, Tackla S., et al.
Publicado: (2019)

Validation of Current Good Manufacturing Practice Compliant Human Pluripotent Stem Cell‐Derived Hepatocytes for Cell‐Based Therapy
por: Blackford, Samuel J.I., et al.
Publicado: (2018)

Enhanced structure and function of human pluripotent stem cell‐derived beta‐cells cultured on extracellular matrix
por: Singh, Reena, et al.
Publicado: (2020)

In depth functional characterization of human induced pluripotent stem cell-derived beta cells in vitro and in vivo
por: Fantuzzi, Federica, et al.
Publicado: (2022)

Generation of induced pluripotent stem cell-derived beta-cells in blood amino acids-like medium
por: Ali, Marwa, et al.
Publicado: (2023)

Manufacturing with pluripotent stem cells (PSConf 2021): Key issues for future research and development
por: Stacey, Glyn N., et al.
Publicado: (2022)

Therapeutic potential of clinical-grade human induced pluripotent stem cell-derived cardiac tissues
por: Osada, Hiroaki, et al.
Publicado: (2021)

BCL-xL/BCL2L1 is a critical anti-apoptotic protein that promotes the survival of differentiating pancreatic cells from human pluripotent stem cells
por: Loo, Larry Sai Weng, et al.
Publicado: (2020)

Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions
por: Wang, Juan, et al.
Publicado: (2015)

Human pluripotent stem cell-derived products: Advances towards robust, scalable and cost-effective manufacturing strategies
por: Jenkins, Michael J, et al.
Publicado: (2015)

Validation of an automated cell counting method for cGMP manufacturing of human induced pluripotent stem cells
por: Manzini, Paolo, et al.
Publicado: (2022)

Differentiation of beta-like cells from human induced pluripotent stem cell-derived pancreatic progenitor organoids
por: Pedraza-Arevalo, Sergio, et al.
Publicado: (2022)

Pluripotency of induced pluripotent stem cells
por: Kang, Lan, et al.
Publicado: (2012)

Pluripotency of Induced Pluripotent Stem Cells
por: Feng, Chunjing, et al.
Publicado: (2013)

Generation of Transplantable Retinal Photoreceptors from a Current Good Manufacturing Practice‐Manufactured Human Induced Pluripotent Stem Cell Line
por: Zhu, Jie, et al.
Publicado: (2017)

Cell Culture Process Scale-Up Challenges for Commercial-Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products
por: Lee, Brian, et al.
Publicado: (2022)

Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells
por: Ohmine, Seiga, et al.
Publicado: (2011)

Derivation of trophoblast stem cells from naïve human pluripotent stem cells
por: Dong, Chen, et al.
Publicado: (2020)

Induced pluripotent stem cells are induced pluripotent stem cell-like cells
por: Song, Liting, et al.
Publicado: (2015)

Methods to produce induced pluripotent stem cell-derived mesenchymal stem cells: Mesenchymal stem cells from induced pluripotent stem cells
por: Dupuis, Victoria, et al.
Publicado: (2021)

In vitro beta-cell killing models using immune cells and human pluripotent stem cell-derived islets: Challenges and opportunities
por: Halliez, Clémentine, et al.
Publicado: (2023)

Micro-management of pluripotent stem cells
por: Guo, Wen-Ting, et al.
Publicado: (2014)

A Roadmap for Human Liver Differentiation from Pluripotent Stem Cells
por: Ang, Lay Teng, et al.
Publicado: (2018)

Hematopoietic cell differentiation from embryonic and induced pluripotent stem cells
por: Lim, Wai Feng, et al.
Publicado: (2013)

cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications
por: Baghbaderani, Behnam Ahmadian, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_28l35ll3638v1ri2gpglplvnhv